Loading
PDBj
MenuPDBj@FacebookPDBj@TwitterPDBj@YouTubewwPDB FoundationwwPDB
RCSB PDBPDBeBMRBAdv. SearchSearch help

8YKI

FGFR-1 in complex with ligand tasurgratinib

This is a non-PDB format compatible entry.
Summary for 8YKI
Entry DOI10.2210/pdb8yki/pdb
DescriptorFibroblast growth factor receptor 1, Tasurgratinib, CHLORIDE ION, ... (4 entities in total)
Functional Keywordsfgf receptor kinase, proteros biostructures gmbh, transferase
Biological sourceHomo sapiens (human)
Total number of polymer chains2
Total formula weight73479.18
Authors
Ikemori-Kawada, M.,Watanabe Miyano, S. (deposition date: 2024-03-05, release date: 2024-06-12)
Primary citationKawano, S.,Kawada, M.I.,Fukushima, S.,Arai, Y.,Shibata, T.,Miyano, S.W.
Antitumor Activity of Tasurgratinib as an Orally Available FGFR1-3 Inhibitor in Cholangiocarcinoma Models With FGFR2-fusion.
Anticancer Res., 44:2393-2406, 2024
Cited by
PubMed: 38821585
DOI: 10.21873/anticanres.17046
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (2.79 Å)
Structure validation

222624

PDB entries from 2024-07-17

PDB statisticsPDBj update infoContact PDBjnumon